Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement

Rupa Ahluwalia(Norfolk and Norwich University Hospitals NHS Foundation Trust), Simon H. S. Pearce(Royal Victoria Infirmary), Julia Priestley(British Thyroid Foundation), Nicola N. Zammitt(Edinburgh Royal Infirmary), Krishna Chatterjee(University of Cambridge), Onyebuchi Okosieme(Cwm Taf University Health Board), Peter Taylor(University Hospital of Wales), Bijay Vaidya(University of Exeter), Stephanie E Baldeweg(University College Hospital), Kristien Boelaert(University of Birmingham), Colin Dayan(University of Birmingham)
Clinical Endocrinology
June 5, 2023
10.1111/cen.14935
Cited by 32

Related Papers

Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
|The Lancet|2023|838
Clonal dynamics of haematopoiesis across the human lifespan
|Nature|2022|505
Human Metabolic Syndrome Resulting From Dominant-Negative Mutations in the Nuclear Receptor Peroxisome Proliferator-Activated Receptor-γ
|Diabetes|2003|429
Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth
|JAMA|2019|395